Inovio pharmaceuticals ceo
WebApr 10, 2024 · Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), … WebApr 12, 2024 · INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer, and infectious diseases, today announced that an abstract has been accepted for presentation for INO-4201 as an Ebola booster for rVSV-ZEBOV (Ervebo) at …
Inovio pharmaceuticals ceo
Did you know?
WebDuring a meeting of the White House Coronavirus Task Force in March 2024, CEO, Joseph Kim, said that Inovio scientists had designed a vaccine candidate (INO-4800) for the … WebFeb 4, 2024 · Inovio Pharmaceuticals Inc has a market cap of $2.98 billion; its shares were traded at around $14.560000 with and P/S ratio of 856.49. GuruFocus has detected 5 …
WebMar 31, 2024 · J. Kim became the CEO of Inovio Pharmaceuticals, Inc. ( NASDAQ:INO) in 2009. This analysis aims first to contrast CEO compensation with other companies that … WebMay 10, 2024 · Since joining as Chief Operating Officer in March 2024, Dr. Shea has shown exceptional leadership and technical expertise overseeing INOVIO's manufacturing, …
WebAug 19, 2015 · INOVIO Pharmaceuticals, Inc. Jun 2009 - Present13 years 11 months Member of the Board of Trustees International Vaccine Institute (IVI) Nov 2013 - Feb 20246 years 4 months Chair, Compensation... Web2 days ago · Inovio Pharmaceuticals Inc. closed $2.48 short of its 52-week high ($3.42), which the company achieved on April 14th. The stock outperformed some of its competitors Thursday, as Johnson &...
WebMay 11, 2024 · Inovio's Kim out as CEO, company shifts focus from Covid-19 vaccine to booster By John George – Senior Reporter, Philadelphia Business Journal May 11, 2024 In …
WebMar 12, 2024 · Effective immediately, Inovio's global clinical and R&D functions will report to Dr. Laurent Humeau, Inovio's Chief Scientific Officer and Executive Vice President. As a part of this... easynuts.nlWebAug 26, 2024 · Kim departed Inovio in May of this year, and the company is now led by Jacqueline Shea. Last month, Shea announced a major restructuring plan for Inovio that included reducing its workforce by... easynuts reviewsWebMay 10, 2024 · The company's net loss of $79.1M in the quarter compares to a loss of $54.4M in Q1 2024. Inovio ( INO) also used its earnings release to state that Jacquelimne Shea has taken over as CEO,... easynvest.com.brWeb1 day ago · Shares of Inovio Pharmaceuticals Inc. INO, -9.05% shed 9.05% to $0.85 Friday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index... easy nut crumble toppingWebMar 15, 2024 · We have the CEO of Inovio Pharmaceuticals, Joseph Kemp, who I've known for a while now joining us for essentially what amounts to a fireside chat. We'll be going … easy nutcracker craftsWebINOVIO Pharmaceuticals, Inc.’s Post INOVIO Pharmaceuticals, Inc. 24,059 followers 1y easy nutella browniesWebKorean American Pharma Society Recognizes CEO's Pioneering Efforts In Developing DNA Vaccines BLUE BELL, Pa. , Nov. 14, 2013 / PRNewswire / - Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that its President & CEO, Dr. J. Joseph Kim , has been selected to receive the 2013 Achievement in Drug Discovery and Development Award … easy nutella cheesecake recipe